HAL (France)open access
Rethinking EPO: A Paradigm Shift in Oncology?
Immunotherapy, Anemia, 1, 0, 2, Erythropoietin, Macrophage, Cancer treatment
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 137348
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.